Freire AG and Butler JM. Blood making: learning what to put into the dish [version 1; peer review: 3 approved]. F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.12688/f1000research.21245.1)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
1Center for Discovery and Innovation, Nutley, USA 2Molecular Oncology Program, Georgetown University, Washington D.C., USA
Ana G Freire
Roles:
Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing
Jason M Butler
Roles:
Conceptualization, Writing – Review & Editing
OPEN PEER REVIEW
REVIEWER STATUS
Abstract
The generation of hematopoietic stem cells (HSCs) from pluripotent stem cell (PSC) sources is a long-standing goal that will require a comprehensive understanding of the molecular and cellular factors that determine HSC fate during embryogenesis. A precise interplay between niche components, such as the vascular, mesenchymal, primitive myeloid cells, and the nervous system provides the unique signaling milieu for the emergence of functional HSCs in the aorta-gonad-mesonephros (AGM) region. Over the last several years, the interrogation of these aspects in the embryo model and in the PSC differentiation system has provided valuable knowledge that will continue educating the design of more efficient protocols to enable the differentiation of PSCs into bona fide, functionally transplantable HSCs. Herein, we provide a synopsis of early hematopoietic development, with particular focus on the recent discoveries and remaining questions concerning AGM hematopoiesis. Moreover, we acknowledge the recent advances towards the generation of HSCs in vitro and discuss possible approaches to achieve this goal in light of the current knowledge.
Corresponding author:
Jason M Butler
Competing interests:
No competing interests were disclosed.
Grant information:
Ana G. Freire is a New York Stem Cell Foundation – Druckenmiller Fellow. Jason M. Butler is a Scholar of The Leukemia and Lymphoma Society. This research was supported by The New York Stem Cell Foundation, Tri-Institutional Stem Cell Initiative (2014-004), American Society of Hematology Scholar Award, American Federation for Aging Research, National Institutes of Health (1R01CA204308, 1R01HL133021, and 1R01AG065436), and the Leukemia and Lymphoma Society Quest for Cures.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Throughout the lifespan of an organism, the supply of blood cells is guaranteed by hematopoietic stem cells (HSCs) that replenish lineage-restricted progenitors while maintaining their stem cell pool. Because these cells are capable of sustaining the entirety of the blood hierarchy, they constitute a cellular source for transfusion, immunotherapies, and transplantation. HSC transplantation constitutes a crucial therapy for hematological disorders. However, the supply for patients is insufficient owing to shortage of histocompatible donors and limited cell number. Thus, the ability to generate HSCs in vitro will provide access to an unlimited number of cells that are capable of long-term reconstitution of all blood cell lineages. The derivation of embryonic stem cells (ESCs) and, subsequently, induced pluripotent stem cells (iPSCs) has provided the platforms to, in theory, derive HSCs given their intrinsic property to generate derivatives of the three germ layers. Yet, despite innumerous efforts, the generation of HSCs from non-genetically manipulated mouse or human pluripotent stem cells (hPSCs) has still not been successful. A full understanding of how HSC fate is specified during embryo development is crucial, as it will provide useful cues to educate the design of in vitro differentiation protocols. The inefficacy in doing so thus far is related to the inherent complexity of the hematopoietic developmental process and the incomplete identification of all the critical factors that make HSC specification possible in the embryo. Comprehension of the initiating events underlying the emergence of the distinct hematopoietic waves endowed with different lineage potential as well as of the microenvironmental cues that instruct and nurture HSC emergence, maturation, and expansion is fundamental. In the following sections, we will revisit the knowledge in early hematopoietic development, with particular focus on the events occurring in the aorta-gonad-mesonephros (AGM) region, the location where HSCs are first detected in the embryo, from the origin of the HSC precursor to the molecules and niche components that guide HSC fate. Lastly, we will review recent advances in the attempt to generate long-term HSCs in the dish and the important contributions these studies provided to get closer to the Holy Grail of the hematopoietic field.
Early hematopoietic development at a glance
Blood formation is a conserved process among vertebrates that occurs in several waves, contributing different hematopoietic cell types in the yolk sac (extraembryonic) and within the embryo proper (intraembryonic). The first hematopoietic wave, called primitive hematopoiesis, emerges within the yolk sac blood islands around embryonic day (E) 7.0–7.5 in the mouse. Hematopoietic differentiation at this stage is limited to cells of the erythroid, macrophage, and megakaryocytic lineages and serves the needs of a rapidly growing embryo1. Following the formation of primitive cells, a second wave contributes with erythro-myeloid progenitors (EMPs) as well as lymphomyeloid, B-1, and T cell-restricted progenitors before the emergence of HSCs2–6. Because the first and second waves arise before the first adult-type HSCs are detected in the embryo, they are considered to be HSC-independent hematopoiesis1,7. Interestingly, derivatives of the HSC-independent hematopoiesis persist to adult life, such as the microglia in the brain and the tissue-resident macrophages found in several organs8,9. The existence of long-lived functional blood cells that did not derive from an HSC challenges the classical hierarchical model of adult hematopoiesis. The hallmark of an adult HSC is its capacity of long-term, multilineage reconstitution in adult recipients in a setting of serial transplantation10. This definition set the foundation that HSC emergence begins around E10.5 in the dorsal aorta (DA) and vitelline/umbilical arteries of the mouse embryo11–14. Nascent HSCs are present within intra-aortic clusters in close contact with endothelial cells (ECs) lining the floor of the DA14. In the human, intra-aortic clusters are detected around 27 days of gestation15, with HSC long-term repopulating activity being demonstrated by transplantation assay into immunodeficient mice16.
Observations made 100 years ago led to the hypothesis that blood cells emerging in the DA possess an endothelial origin17,18. More recent studies have provided compelling evidence, through live imaging and lineage tracing, for the existence of a specialized vascular endothelium, the denominated hemogenic endothelium (HE), that undergoes endothelial hematopoietic transition (EHT)19–23. Maturation towards HSC fate occurs through a multi-step differentiation process from hematopoietic precursors (type I and II pre-HSCs) that express genes associated with the endothelial lineage, such as Cdh5 (or VEcad) and Pecam1 (or Cd31) (Figure 1)24–28. Later, it was discovered that HE is not restricted to the developing embryonic vasculature where HSCs emerge, existing also in the yolk sac where it serves as a precursor of primitive erythrocytes29 and EMPs30 as well as B6 and T cells5 prior to HSC emergence.
Figure 1. Representation of the consensually accepted sequential steps of differentiation to adult-type HSCs in the AGM.
HSCs derive from a precursor that descends from mesoderm and expresses endothelial genes, called hemogenic endothelium (HE). HE undergoes endothelial hematopoietic transition (EHT) and maturation to functional HSCs through intermediate HSC precursors (type I and II pre-HSCs). During this process, a precise regulation of the arterial-associated genes Notch1 and Sox17 and of the critical players in EHT, Runx1 and Gata2, takes place. Moreover, hematopoietic markers (i.e. c-Kit, CD41, CD43, and CD45) are upregulated while genes of endothelial affiliation (i.e. VE-Cadherin and CD31) are still expressed24–28. *HSCs are believed to display a similar phenotypic signature to type II pre-HSCs, but their function is demonstrated by transplantation into adult irradiated recipients. AGM, aorta-gonad-mesonephros; E, embryonic day; HSC, hematopoietic stem cell.
The emergence of HSCs in the DA is a highly dynamic and transient phenomenon that declines around E12.5 in the mouse, coinciding with the entrance of HSCs in the bloodstream and seeding of the fetal liver, which will support HSC expansion prior to migration to the fetal spleen and bone marrow28,31. Additional sources where the presence of HSCs has been reported (e.g. the placenta, head, and yolk sac) were suggested to also contribute to the HSC pool in the fetal liver32–36. However, the capacity of these sources to originate HSCs de novo, rather than promoting their expansion, remains a controversial topic which is greatly hampered by the onset of circulation around E8.2535,37–39. Recently, the de novo generation of hematopoietic stem/progenitor cells (HSPCs) from HE existing in the bone marrow of late fetus/young adult chickens and mice has also been suggested40.
Studies using limiting-dilution transplantation assays have estimated that the AGM contains very few HSCs (one to three) and proposed that the rapid increase in HSC number in the fetal liver could be the result of maturation of a large pool of pre-expanded pre-HSCs generated in the AGM region28,32. Recent reports utilizing multicolor fate mapping in zebrafish and mouse models have suggested that the number of hematopoietic precursors emerging at the AGM, and contributing to adult hematopoiesis, is significantly higher than initially predicted41,42. The functional readout of HSCs autonomously generated from the AGM has been facilitated by the utilization of platforms that allow ex vivo maturation and/or expansion, such as organ explant culture12,32,43, co-aggregation culture with OP9 stromal cells24,44, or co-culture with Akt-expressing AGM-derived ECs45,46. It is not until E11.5 that functional AGM-derived HSCs can be robustly detected by direct transplantation into adult recipients, likely because of the achievement of a critical number of HSCs24. The fact that hematopoietic precursors are able to acquire functional properties after a period of ex vivo co-culture with niche cells suggests that these in vitro platforms are able to provide the cues encountered within the embryonic environment. This anticipates that it might be possible to recapitulate in vitro the process of HSC generation if we recreate the complex interactions within the stem cells’ niche.
AGM: the cradle of HSCs
The observation that HE located in the DA and vitelline/umbilical arteries originates HSCs highlights the importance of comprehending the combination of spatiotemporal signals and niche cells that compose the AGM region. Curiously, HE giving rise to functional HSCs is detected only within the large arteries of the embryo, whereas HE in the yolk sac is associated with both arterial and venous endothelium13,30,47. This evidence, combined with the observation of direct hematopoietic cell emergence from aortic endothelium, led to the hypothesis that acquisition of arterial identity precedes HSC emergence. The origin of the aortic HE and whether it shares a common lineage with arterial endothelium is still a topic of debate. The loss of critical regulators of arterial identity, such as SOX17 and NOTCH148–50, is detrimental for HSC generation or maintenance in the mouse embryo51,52. However, a tight control of the activity of these pathways is required to ensure proper HSC specification, with downregulation being necessary during formation of the hematopoietic clusters53,54. RUNX1 and GATA2 are also indispensable players during EHT (Figure 1) in the zebrafish, chick, and mouse AGM and during ESC differentiation23,55–60, whose timing and duration of intervention are tightly controlled61,62. Nevertheless, studies that have reported the presence of hematopoietic precursors in the subendothelial aortic layers in the mouse AGM region added complexity to our understanding of the origin of the HE24,63. In addition, it has been recently shown in the chicken that the coelomic epithelium-derived mesenchyme invades through the ventral wall of the DA prior to formation of the intra-aortic clusters64. Studies in hPSCs have identified HE and non-HE lineages during in vitro differentiation65 and have suggested that the HE and the precursors of the arterial vascular endothelium represent distinct lineages deriving from hPSC-derived mesodermal progenitors66. These observations during hPSC in vitro differentiation led to a proposed model of human HE development, in which HE in the subaortic mesenchyme migrates to the AGM region to integrate with the arterial ECs within the ventral wall of the DA67. Later studies in hPSCs suggested that, after specifying from mesodermal progenitors, HE can be specified into an arterial-type HE with lymphoid and myeloid potential in vitro through overexpression of Ets1 or modulation of MAPK/ERK signaling in a process dependent on Notch signaling68,69. Recently, RNA-sequencing studies in the mouse embryo revealed that the aortic HE transcriptome is very similar to that of arterial ECs of the DA26,70 and distinct from the yolk sac HE70. Additionally, a recent single-cell RNA-sequencing study in human AGM reported that the HE displays an arterial gene signature71. Moreover, a study in zebrafish using a BAC runx1 transgenic reporter showed that runx1 expression in HE mediates silencing of arterial endothelial genes, including dll4, while runx1–/– mutants maintain arterial identity72. This finding reconciles the previous demonstration that cells in the mouse DA that experience high levels of NOTCH1 activity through DLL4 are committed to arterial EC fate, whereas specification of HSCs depends on low levels of NOTCH1 enabled by JAGGED173. Furthermore, it suggests the aortic endothelium is the precursor of HE72, in line with earlier evidence provided by live imaging and lineage tracing studies in the chick, zebrafish, and mouse embryo19,21–23,74.
An important observation is that the emergence of intra-aortic clusters is located at the ventral wall of the DA in the chick, zebrafish, and human AGM15,19,21,23. In the mouse, although mostly ventralized, some clusters are also found along the dorsal wall22,75,76. Yet repopulating activity is predominantly restricted to intra-aortic clusters localized ventrally in the DA75. A plausible explanation might be that ventral aortic ECs, conversely to dorsal ECs, derive from splanchnopleural mesoderm, which is endowed with hematopoietic potential77. The dorsoventral polarity of HSC function correlates with asymmetric signaling in the embryonic DA, with polarized Sonic Hedgehog (SHH) and bone morphogenetic protein 4 (BMP4) signaling and Kit ligand (KITL) expression being reported78–80. Reinforcing the transient nature of AGM hematopoiesis, a precise control of BMP activity has been shown in mouse and zebrafish in order to restrict HSC formation and allow maturation80–82. In the zebrafish, fibroblast growth factor (FGF) signaling was found to play a role in modulating the BMP pathway82. Moreover, Tenascin C, an extracellular matrix glycoprotein that facilitates cell-to-cell interactions and cell migration, is also abundant in the mesenchymal tissue underneath the ventral wall of the human DA83. A posterior study in hPSCs correlated the high production of Tenascin C in overconfluent OP9 stromal lines with the ability to induce higher hematopoietic potential84.
Contributing to the highly dynamic nature of the AGM, a complex crosstalk between different niche components, including the recruitment of different cellular and molecular factors to the vicinity of the DA, takes place during HSC emergence (Figure 2). The subaortic mesenchyme contributes to HSC formation in the chicken embryo by inducing RUNX1 expression in the ventral aortic endothelium58. Moreover, studies suggested a link between the developing nervous system and enhancement of HSC emergence, as shown by the inductive effect of catecholamines in the mouse85 and neuronal serotonin in the zebrafish86. Interestingly, from the yolk sac-derived wave, macrophages87,88 and neutrophils89 contribute with local sterile inflammatory signaling that promotes HSC emergence. Evidence in the zebrafish further demonstrated that tumor necrosis factor alpha (TNFα) signaling produced by neutrophils triggers JAGGED1-mediated Notch signaling in the aortic endothelial layer, thereby promoting HSC specification89. Furthermore, macrophages establish a close interaction with the emerging intra-aortic hematopoietic cells in zebrafish, human90, and mouse AGM88 and remodel the extracellular matrix, thus permitting HSC mobilization to the caudal hematopoietic tissue (analogous to the mammalian fetal liver in the zebrafish)90. Importantly, HSC repopulating activity was impaired when AGM explants were depleted of macrophages, thus indicating macrophages are crucial for the generation and/or maturation of functional HSCs in the mouse AGM88. In addition, quail/chick orthotopic transplantations have shown that somite-derived ECs contribute distinct waves, first to build the roof of the DA and later to replace the hemogenic floor ceasing hematopoietic generation in the ventral aortic wall91. In the zebrafish, somite-derived ECs integrate the DA while contributing to HSC formation by eliciting inductive signals92. Though phenotypic HSC precursors are found in both subluminal and luminal layers, HSCs are localized exclusively within the endothelial aortic layer24,44, strongly suggesting that the final step of maturation into functional HSCs needs instructive cues from the non-hemogenic vascular niche. Accordingly, hematopoietic precursors are able to expand and mature into functional HSCs after in vitro co-culture with Akt-expressing AGM-derived EC lines45. This could be in part explained by the secretion of KITL by aortic ECs80,93, a key regulator driving pre-HSC/HSC survival and maturation in the AGM region25,80,93. Moreover, Tie2‐Cre::KitlΔ/Δ mice, where Kitl is specifically deleted in the endothelium, showed decreased numbers of phenotypic pre‐HSC II/HSCs in the AGM at E11.5, further resulting in fewer reconstituted mice upon transplantation93. The instructive role of the vascular niche in adult HSC function in the bone marrow, including the supply of KITL, has been extensively demonstrated94. The full understanding of these complex interactions and the identification of all the moving parts that take place in AGM hematopoiesis will help us design protocols that aim to derive HSCs from PSCs.
Figure 2. Representation of niche components that participate during HSC emergence in the AGM.
A precise interplay between niche components, including ECs, mesenchymal cells, primitive myeloid cells, and components of the nervous system, provides the unique signaling milieu for the emergence of HSCs in the AGM region. AGM, aorta-gonad-mesonephros; EC, endothelial cell; EHT, endothelial hematopoietic transition; HSC, hematopoietic stem cell.
The quest for generating HSCs in the dish
Historically, hematopoietic development in vitro recapitulates the patterns observed in the embryo, following a step-wise differentiation toward induction and patterning of the mesoderm and commitment to the distinct hematopoietic waves67. Although differentiation of PSCs to multiple blood cell types is feasible, the generation of bona fide blood stem cells is still a challenge. Strategies utilizing genetic manipulation of mouse ESC-derived hematopoietic progenitors, such as transduction with Hoxb4, reported long-term engraftment in irradiated adult hosts though underperformance in terms of lymphoid contribution95. More recently, a study in non-genetically manipulated mouse ESCs has provided exciting evidence that it might be possible to obtain cells with engrafting ability within a transient time window during differentiation. However, engraftment shown in immunodeficient mice declined over time, and demonstration of repopulation in secondary recipients was not provided96. Despite the innumerous efforts to generate HSCs from human PSCs, studies that have performed transplantation into immunodeficient mice have reported low engraftment efficiency and/or lacked proof of robust lymphoid contribution97–100. Noteworthy, a study in hPSCs utilizing a differentiation protocol that enhances the expression of HOXA genes, shown to be downregulated in PSC-derived hematopoietic progenitors when compared to fetal liver HSPCs and cord blood CD34+ cells101,102, was able to recapitulate an AGM-like vessel network. Yet hematopoietic cells derived using this protocol were not capable of long-term engrafting ability after transplantation102.
Nonetheless, studies using PSCs have contributed valuable information on early cell fate determination, such as the identification of signals that repress specification into primitive hematopoiesis (i.e. inhibition of ACTIVIN-NODAL signaling and activation of WNT during early stages of differentiation)102–104. Moreover, observations in this in vitro system suggest that an early mesoderm-derived HE specifies into distinct subsets that differ in the hematopoietic lineage potential68,69,105,106. In the attempt to foster hematopoietic instruction by providing niche signals, some studies have established co-cultures with human umbilical vein endothelial cells97,106 or AGM-derived stromal cell lines98,107. The growing knowledge on the molecular and cellular factors that instruct HSC generation and maturation will be crucial for the implementation of efficient protocols to derive HSC fate in vitro.
Conclusions
The ability to generate bona fide blood stem cells from PSCs has been intensively investigated given the impact it would have in clinical applications. The challenges are related not only to the incomplete knowledge of all the critical factors important for HSC emergence but also to the inherent complexity of the hematopoietic developmental process. In light of the understanding that erythroid-myeloid and B and T lymphoid potential is detected prior to repopulating capacity, it becomes unclear whether hematopoietic cells obtained during PSC differentiation, including T cells, represent the in vitro counterpart of the HSC-independent hematopoiesis occurring in the embryo. Because of the obstacles posed by direct differentiation in vitro, several laboratories have made efforts to achieve this goal by using the reprogramming strategy. Recent studies have reported the generation of hematopoietic cells with long-term repopulating ability and immune competence108,109. Towards a safer approach, the successful generation of HSCs from reprogramming methods that do not require transgene integration will need to be tested. The generation of HSCs in the dish, by exposing PSCs to signaling cues that mimic the embryo environment, would be the safest approach. The challenge here is to identify the combination of soluble factors and inhibitors and the niche components required to drive specification of HSC fate. The recent discoveries documenting new cell types and signaling molecules that participate during AGM hematopoiesis added valuable information to the field and will help to establish in vitro differentiation protocols. The current knowledge supports the idea that the aortic endothelium is pivotal for HSC emergence. A specialized hemogenic endothelium, in a complex crosstalk with other cell types, undergoes EHT mediated by the interplay of several transcriptional regulators that act transiently to specify hematopoietic fate. Simultaneously, non-hemogenic ECs provide instructive cues that enable the generation of functional HSCs. Thus, to mimic the transient nature of AGM hematopoiesis, a fine tuning of the signaling milieu will have to take place to ensure progression of EHT and generation of functional HSCs. Importantly, given the evidence that several niche components are essential for HSC emergence and maturation, the niche cells need to be included in the equation. This could be attempted either by direct co-culture or by supplementing the culture with key factors provided by the niche cells. Moreover, provided that HSC emergence is achieved, culture conditions will need to support maturation and expansion to numbers that can robustly engraft adult recipients in a transplantation setting, the only reliable readout assay to confirm the presence of functional long-term HSCs. The ability to expand long-term reconstituting HSCs from adult bone marrow or umbilical cord blood (UCB) sources ex vivo has also demonstrated challenges. Earlier attempts have established in vitro culture conditions that did not support the expansion to relevant cell numbers and/or caused adverse effects on HSPCs that resulted in improper differentiation110. More recently, the incorporation of the small molecules SR-1111 and UM171112 or valproic acid113 or direct co-culture with ECs114 to serum-free media supplemented with cytokines has shown robust levels of CD34+-UCB expansion with long-term repopulating ability. The ex vivo vascular niche platform has also been shown to support the expansion of engraftable adult bone marrow-derived CD34+ cells115. Interestingly, a protocol that enables long-term ex vivo culture of mouse adult bone marrow HSCs that expand robustly and maintain their functionality has been reported recently116. Proven the robust generation and expansion of bona fide blood stem cells by direct differentiation from PSCs in vitro, the Holy Grail in the field will be ultimately achieved, providing not only an in vitro platform to model development and hematological diseases but also an unlimited source of cells for clinical applications.
The authors thank the members of the Butler Lab for useful discussions.
Faculty Opinions recommended
References
1.
Palis J:
Hematopoietic stem cell-independent hematopoiesis: Emergence of erythroid, megakaryocyte, and myeloid potential in the mammalian embryo.
FEBS Lett.
2016; 590(22): 3965–3974. PubMed Abstract
| Publisher Full Text
2.
Böiers C, Carrelha J, Lutteropp M, et al.:
Lymphomyeloid Contribution of an Immune-Restricted Progenitor Emerging Prior to Definitive Hematopoietic Stem Cells.
Cell Stem Cell.
2013; 13(5): 535–48. PubMed Abstract
| Publisher Full Text
| Faculty Opinions Recommendation
3.
McGrath KE, Frame JM, Fegan KH, et al.:
Distinct Sources of Hematopoietic Progenitors Emerge before HSCs and Provide Functional Blood Cells in the Mammalian Embryo.
Cell Rep.
2015; 11(12): 1892–904. PubMed Abstract
| Publisher Full Text
| Free Full Text
5.
Yoshimoto M, Porayette P, Glosson NL, et al.:
Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence.
Blood.
2012; 119(24): 5706–14. PubMed Abstract
| Publisher Full Text
| Free Full Text
6.
Yoshimoto M, Montecino-Rodriguez E, Ferkowicz MJ, et al.:
Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential.
Proc Natl Acad Sci U S A.
2011; 108(4): 1468–73. PubMed Abstract
| Publisher Full Text
| Free Full Text
11.
Müller AM, Medvinsky A, Strouboulis J, et al.:
Development of hematopoietic stem cell activity in the mouse embryo.
Immunity.
1994; 1(4): 291–301. PubMed Abstract
| Publisher Full Text
12.
Medvinsky A, Dzierzak E:
Definitive hematopoiesis is autonomously initiated by the AGM region.
Cell.
1996; 86(6): 897–906. PubMed Abstract
| Publisher Full Text
13.
Bruijn MF de, Speck NA, Peeters MC, et al.:
Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo.
EMBO J.
2000; 19(11): 2465–74. PubMed Abstract
| Publisher Full Text
| Free Full Text
15.
Tavian M, Hallais MF, Péault B:
Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo.
Development.
1999; 126(4): 793–803. PubMed Abstract
17.
Emmel VE:
The cell clusters in the dorsal aorta of mammalian embryos.
Am J Anat.
1916; 19(3): 401–421. Publisher Full Text
18.
Jordan HE:
Evidence of hemogenic capacity of endothelium.
Anat Rec.
1916; 10(5): 417–420. Publisher Full Text
19.
Jaffredo T, Gautier R, Eichmann A, et al.:
Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny.
Development.
1998; 125(22): 4575–83. PubMed Abstract
20.
Eilken HM, Nishikawa SI, Schroeder T:
Continuous single-cell imaging of blood generation from haemogenic endothelium.
Nature.
2009; 457(7231): 896–900. PubMed Abstract
| Publisher Full Text
22.
Boisset JC, van Cappellen W, Andrieu-Soler C, et al.:
In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium.
Nature.
2010; 464(7285): 116–20. PubMed Abstract
| Publisher Full Text
25.
Rybtsov S, Batsivari A, Bilotkach K, et al.:
Tracing the origin of the HSC hierarchy reveals an SCF-dependent, IL-3-independent CD43- embryonic precursor.
Stem Cell Reports.
2014; 3(3): 489–501. PubMed Abstract
| Publisher Full Text
| Free Full Text
30.
Frame JM, Fegan KH, Conway SJ, et al.:
Definitive Hematopoiesis in the Yolk Sac Emerges from Wnt-Responsive Hemogenic Endothelium Independently of Circulation and Arterial Identity.
Stem Cells.
2016; 34(2): 431–44. PubMed Abstract
| Publisher Full Text
| Free Full Text
32.
Kumaravelu P, Hook L, Morrison AM, et al.:
Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver.
Development.
2002; 129(21): 4891–9. PubMed Abstract
| Faculty Opinions Recommendation
33.
Ottersbach K, Dzierzak E:
The murine placenta contains hematopoietic stem cells within the vascular labyrinth region.
Dev Cell.
2005; 8(3): 377–87. PubMed Abstract
| Publisher Full Text
36.
Li Z, Vink CS, Mariani SA, et al.:
Subregional localization and characterization of Ly6aGFP-expressing hematopoietic cells in the mouse embryonic head.
Dev Biol.
2016; 416(1): 34–41. PubMed Abstract
| Publisher Full Text
| Free Full Text
43.
Taoudi S, Morrison AM, Inoue H, et al.:
Progressive divergence of definitive haematopoietic stem cells from the endothelial compartment does not depend on contact with the foetal liver.
Development.
2005; 132(18): 4179–91. PubMed Abstract
| Publisher Full Text
44.
Taoudi S, Gonneau C, Moore K, et al.:
Extensive hematopoietic stem cell generation in the AGM region via maturation of VE-cadherin+CD45+ pre-definitive HSCs.
Cell Stem Cell.
2008; 3(1): 99–108. PubMed Abstract
| Publisher Full Text
| Faculty Opinions Recommendation
45.
Hadland BK, Varnum-Finney B, Poulos MG, et al.:
Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells.
J Clin Invest.
2015; 125(5): 2032–45. PubMed Abstract
| Publisher Full Text
| Free Full Text
47.
Gordon-Keylock S, Sobiesiak M, Rybtsov S, et al.:
Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs.
Blood.
2013; 122(14): 2338–45. PubMed Abstract
| Publisher Full Text
| Free Full Text
49.
Lawson ND, Scheer N, Pham VN, et al.:
Notch signaling is required for arterial-venous differentiation during embryonic vascular development.
Development.
2001; 128(19): 3675–83. PubMed Abstract
50.
Clarke RL, Yzaguirre AD, Yashiro-Ohtani Y, et al.:
The expression of Sox17 identifies and regulates haemogenic endothelium.
Nat Cell Biol.
2013; 15(5): 502–10. PubMed Abstract
| Publisher Full Text
| Free Full Text
53.
Lizama CO, Hawkins JS, Schmitt CE, et al.:
Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition.
Nat Commun.
2015; 6: 7739. PubMed Abstract
| Publisher Full Text
| Free Full Text
56.
Robert-Moreno A, Espinosa L, de la Pompa JL, et al.:
RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells.
Development.
2005; 132(5): 1117–26. PubMed Abstract
| Publisher Full Text
61.
Chen MJ, Yokomizo T, Zeigler BM, et al.:
Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.
Nature.
2009; 457(7231): 887–91. PubMed Abstract
| Publisher Full Text
| Free Full Text
62.
Guiu J, Shimizu R, D’Altri T, et al.:
Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling.
J Exp Med.
2013; 210(1): 71–84. PubMed Abstract
| Publisher Full Text
| Free Full Text
63.
Bertrand JY, Giroux S, Golub R, et al.:
Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin.
Proc Natl Acad Sci U S A.
2005; 102(1): 134–9. PubMed Abstract
| Publisher Full Text
| Free Full Text
64.
Arraf AA, De Bruijn MFTR, Schultheiss TM:
Disruption of the aortic wall by coelomic lining-derived mesenchymal cells accompanies the onset of aortic hematopoiesis.
Int J Dev Biol.
2017; 61(3–4–5): 329–335. PubMed Abstract
| Publisher Full Text
| Faculty Opinions Recommendation
65.
Choi KD, Vodyanik MA, Togarrati PP, et al.:
Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.
Cell Rep.
2012; 2(3): 553–67. PubMed Abstract
| Publisher Full Text
| Free Full Text
75.
Taoudi S, Medvinsky A:
Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta.
Proc Natl Acad Sci U S A.
2007; 104(22): 9399–403. PubMed Abstract
| Publisher Full Text
| Free Full Text
77.
Pardanaud L, Luton D, Prigent M, et al.:
Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis.
Development.
1996; 122(5): 1363–71. PubMed Abstract
78.
Marshall CJ, Kinnon C, Thrasher AJ:
Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region.
Blood.
2000; 96(4): 1591–3. PubMed Abstract
| Publisher Full Text
79.
Wilkinson RN, Pouget C, Gering M, et al.:
Hedgehog and Bmp polarize hematopoietic stem cell emergence in the zebrafish dorsal aorta.
Dev Cell.
2009; 16(6): 909–16. PubMed Abstract
| Publisher Full Text
| Free Full Text
80.
Souilhol C, Gonneau C, Lendinez JG, et al.:
Inductive interactions mediated by interplay of asymmetric signalling underlie development of adult haematopoietic stem cells.
Nat Commun.
2016; 7: 10784. PubMed Abstract
| Publisher Full Text
| Free Full Text
82.
Pouget C, Peterkin T, Simões FC, et al.:
FGF signalling restricts haematopoietic stem cell specification via modulation of the BMP pathway.
Nat Commun.
2014; 5: 5588. PubMed Abstract
| Publisher Full Text
| Free Full Text
83.
Marshall CJ, Moore RL, Thorogood P, et al.:
Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer.
Dev Dyn.
1999; 215(2): 139–47. PubMed Abstract
| Publisher Full Text
84.
Uenishi G, Theisen D, Lee JH, et al.:
Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions.
Stem Cell Reports.
2014; 3(6): 1073–84. PubMed Abstract
| Publisher Full Text
| Free Full Text
86.
Kwan W, Cortes M, Frost I, et al.:
The Central Nervous System Regulates Embryonic HSPC Production via Stress-Responsive Glucocorticoid Receptor Signaling.
Cell Stem Cell.
2016; 19(3): 370–82. PubMed Abstract
| Publisher Full Text
| Free Full Text
87.
Li Y, Esain V, Teng L, et al.:
Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production.
Genes Dev.
2014; 28(23): 2597–612. PubMed Abstract
| Publisher Full Text
| Free Full Text
91.
Pouget C, Gautier R, Teillet MA, et al.:
Somite-derived cells replace ventral aortic hemangioblasts and provide aortic smooth muscle cells of the trunk.
Development.
2006; 133(6): 1013–22. PubMed Abstract
| Publisher Full Text
94.
Ramalingam P, Poulos MG, Butler JM:
Regulation of the hematopoietic stem cell lifecycle by the endothelial niche.
Curr Opin Hematol.
2017; 24(4): 289–299. PubMed Abstract
| Publisher Full Text
| Free Full Text
96.
Pearson S, Cuvertino S, Fleury M, et al.:
In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation.
Stem Cell Reports.
2015; 4(3): 431–44. PubMed Abstract
| Publisher Full Text
| Free Full Text
98.
Ledran MH, Krassowska A, Armstrong L, et al.:
Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches.
Cell Stem Cell.
2008; 3(1): 85–98. PubMed Abstract
| Publisher Full Text
| Faculty Opinions Recommendation
99.
Lu M, Kardel MD, O'Connor MD, et al.:
Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells.
Exp Hematol.
2009; 37(8): 924–36. PubMed Abstract
| Publisher Full Text
100.
Wang L, Menendez P, Shojaei F, et al.:
Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression.
J Exp Med.
2005; 201(10): 1603–14. PubMed Abstract
| Publisher Full Text
| Free Full Text
102.
Ng ES, Azzola L, Bruveris FF, et al.:
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros.
Nat Biotechnol.
2016; 34(11): 1168–1179. PubMed Abstract
| Publisher Full Text
103.
Sturgeon CM, Ditadi A, Awong G, et al.:
Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.
Nat Biotechnol.
2014; 32(6): 554–61. PubMed Abstract
| Publisher Full Text
| Free Full Text
104.
Kennedy M, Awong G, Sturgeon CM, et al.:
T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.
Cell Rep.
2012; 2(6): 1722–35. PubMed Abstract
| Publisher Full Text
106.
Rafii S, Kloss CC, Butler JM, et al.:
Human ESC-derived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition.
Blood.
2013; 121(5): 770–80. PubMed Abstract
| Publisher Full Text
107.
Gordon-Keylock SAM, Jackson M, Huang C, et al.:
Induction of hematopoietic differentiation of mouse embryonic stem cells by an AGM-derived stromal cell line is not further enhanced by overexpression of HOXB4.
Stem Cells Dev.
2010; 19(11): 1687–98. PubMed Abstract
| Publisher Full Text
| Free Full Text
114.
Butler JM, Gars EJ, James DJ, et al.:
Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.
Blood.
2012; 120(6): 1344–7. PubMed Abstract
| Publisher Full Text
| Free Full Text
115.
Gori JL, Butler JM, Kunar B, et al.:
Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
Stem Cells Transl Med.
2017; 6(3): 864–876. PubMed Abstract
| Publisher Full Text
| Free Full Text
Ana G. Freire is a New York Stem Cell Foundation – Druckenmiller Fellow. Jason M. Butler is a Scholar of The Leukemia and Lymphoma Society. This research was supported by The New York Stem Cell Foundation, Tri-Institutional Stem Cell Initiative (2014-004), American Society of Hematology Scholar Award, American Federation for Aging Research, National Institutes of Health (1R01CA204308, 1R01HL133021, and 1R01AG065436), and the Leukemia and Lymphoma Society Quest for Cures.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Freire AG and Butler JM. Blood making: learning what to put into the dish [version 1; peer review: 3 approved] F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.12688/f1000research.21245.1)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.
Share
Open Peer Review
Current Reviewer Status:
?
Key to Reviewer Statuses
VIEWHIDE
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Slukvin I. Reviewer Report For: Blood making: learning what to put into the dish [version 1; peer review: 3 approved]. F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.5256/f1000research.23396.r58571)
I confirm that I have read this submission and believe that I have an
... Continue reading
Competing Interests: No competing interests were disclosed.
Faculty Reviews are commissioned and written by members of the prestigious Faculty Opinions Faculty, and are edited as a service to our readers. In order to make these reviews as comprehensive and accessible as possible, we seek the reviewers’ input before publication. The reviewers’ names and any additional comments they may have are published alongside the review, as is usual on F1000Research.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
Slukvin I. Reviewer Report For: Blood making: learning what to put into the dish [version 1; peer review: 3 approved]. F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.5256/f1000research.23396.r58571)
Kouskoff V. Reviewer Report For: Blood making: learning what to put into the dish [version 1; peer review: 3 approved]. F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.5256/f1000research.23396.r58570)
I confirm that I have read this submission and believe that I have an
... Continue reading
Competing Interests: No competing interests were disclosed.
Faculty Reviews are commissioned and written by members of the prestigious Faculty Opinions Faculty, and are edited as a service to our readers. In order to make these reviews as comprehensive and accessible as possible, we seek the reviewers’ input before publication. The reviewers’ names and any additional comments they may have are published alongside the review, as is usual on F1000Research.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
Kouskoff V. Reviewer Report For: Blood making: learning what to put into the dish [version 1; peer review: 3 approved]. F1000Research 2020, 9(F1000 Faculty Rev):38 (https://doi.org/10.5256/f1000research.23396.r58570)
I confirm that I have read this submission and believe that I have an
... Continue reading
Competing Interests: No competing interests were disclosed.
Faculty Reviews are commissioned and written by members of the prestigious Faculty Opinions Faculty, and are edited as a service to our readers. In order to make these reviews as comprehensive and accessible as possible, we seek the reviewers’ input before publication. The reviewers’ names and any additional comments they may have are published alongside the review, as is usual on F1000Research.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations -
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Adjust parameters to alter display
View on desktop for interactive features
Includes Interactive Elements
View on desktop for interactive features
Competing Interests Policy
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Examples of 'Non-Financial Competing Interests'
Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.
You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.
You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).
You work at the same institute as any of the authors.
You hope/expect to benefit (e.g. favour or employment) as a result of your submission.
You are an Editor for the journal in which the article is published.
Examples of 'Financial Competing Interests'
You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.
You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.
You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.
Stay Updated
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Comments on this article Comments (0)